Adaptation of a Quality of Life Questionnaire for Iranian Patients with Esophageal Cancer

Overview

Journal Indian J Palliat Care

Specialty Critical Care

Date 2014 Aug 16

PMID 25125868

Citations 2

Authors

Mojgan Forootan

Morteza Tabatabaeefar

Nakisa Maghsoodi

Maryam Ardeshiri

Mahdi Fatemi

Hormat Rahimzadeh

Affiliations

Soon will be listed here.

Abstract

Introduction: Evaluation of quality of life is very important in cancer patients. Esophagus-specific quality of life questionnaire (QLQ-OES18) is a disease-specific questionnaire for assessing quality of life in esophageal cancer (EC). So we aimed to translate and evaluate the reliability and validity of the QLQ-OES18 when applied to Iranian patients.

Materials And Methods: This study was designed as cross-sectional study on 62 newly confirmed EC in two referral hospital in Tehran, Iran. Reliability of the subscales was evaluated by intraclass correlation coefficients. Pearson's correlations of an item with its own scale and other scales were calculated to assess convergent and discriminant validity. Clinical validity was also evaluated by known-group comparisons.

Results: Cronbach's alpha was higher than 0.7 in most subscales. All subscales met the standards of convergent and discriminant validity. Also QLQ-OES18 had discriminatory power for differentiation between patient's groups with different clinical status.

Conclusion: Our results provide evidences that Persian version of QLQ-OES18 is a valid and reliable questionnaire when applied to a sample of Iranian patients with EC and is recommended for use in clinical research.

Citing Articles

Comparison of sublingual buprenorphine and intravenous morphine in reducing bone metastases associated pain in cancer patients.

Jamalian S, Sotodeh M, Mohaghegh F Eur J Transl Myol. 2019; 29(2):8098.

PMID: 31354919 PMC: 6615365. DOI: 10.4081/ejtm.2019.8098.

A comparative study on the efficacy of fast-track surgery in the treatment of esophageal cancer patients combined with metabolic syndrome.

Zhang Z, Li H, Yan C, Xu B, Hu R, Ma M Oncol Lett. 2017; 14(4):4812-4816.

PMID: 29085484 PMC: 5649696. DOI: 10.3892/ol.2017.6759.

References

Blazeby J, Farndon J, Donovan J, Alderson D . A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 2000; 88(8):1781-7. View

Blazeby J, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M . Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003; 39(10):1384-94. DOI: 10.1016/s0959-8049(03)00270-3. View

Pourhoseingholi M, Fazeli Z, Moghimi-Dehkordi B, Vahedi M, Pourhoseingholi A, Safaee A . Increased oesophageal cancer mortality rate in Iran. Arab J Gastroenterol. 2012; 13(2):82-4. DOI: 10.1016/j.ajg.2012.06.008. View

Russel M, Pastoor C, Brandon S, Rijken J, Engels L, van der Heijde D . Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997; 58(3):282-8. DOI: 10.1159/000201455. View

Safaee A, Moghim Dehkordi B . Validation study of a quality of life (QOL) questionnaire for use in Iran. Asian Pac J Cancer Prev. 2008; 8(4):543-6. View

Ciccocioppo R, Klersy C, Russo M, Valli M, Boccaccio V, Imbesi V . Validation of the Italian translation of the Inflammatory Bowel Disease Questionnaire. Dig Liver Dis. 2011; 43(7):535-41. DOI: 10.1016/j.dld.2010.12.014. View

Maroju N, Anbalagan P, Kate V, Ananthakrishnan N . Improvement in dysphagia and quality of life with self-expanding metallic stents in malignant esophageal strictures. Indian J Gastroenterol. 2006; 25(2):62-5. View

Brunelli C, Mosconi P, Boeri P, Gangeri L, Pizzetti P, Cerrai F . Evaluation of quality of life in patients with malignant dysphagia. Tumori. 2000; 86(2):134-8. DOI: 10.1177/030089160008600205. View

Prieto L, Thorsen H, Juul K . Development and validation of a quality of life questionnaire for patients with colostomy or ileostomy. Health Qual Life Outcomes. 2005; 3:62. PMC: 1274339. DOI: 10.1186/1477-7525-3-62. View

10.

Safaee A, Fatemi S, Moghimi-Dehkordi B, Ghiasi S, Zali M . Epidemiology and histopathological features of esophageal cancer. East Afr J Public Health. 2012; 9(1):7-9. View

11.

Krouse R, Grant M, Ferrell B, Dean G, Nelson R, Chu D . Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res. 2007; 138(1):79-87. DOI: 10.1016/j.jss.2006.04.033. View

12.

Chie W, Tsai C, Chiang C, Lee Y . Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication. Qual Life Res. 2010; 19(8):1127-31. DOI: 10.1007/s11136-010-9675-8. View

13.

Ren W, Lai M, Chen Y, Irvine E, Zhou Y . Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2007; 13(7):903-10. DOI: 10.1002/ibd.20128. View

14.

Kujawski K, Stasiak M, Rysz J . The evaluation of esophageal stenting complications in palliative treatment of dysphagia related to esophageal cancer. Med Sci Monit. 2012; 18(5):CR323-9. PMC: 3560635. DOI: 10.12659/msm.882739. View

15.

Eldeeb H, El-Hadaad H . Radiotherapy versus stenting in treating malignant dysphagia. J Gastrointest Oncol. 2012; 3(4):322-5. PMC: 3492474. DOI: 10.3978/j.issn.2078-6891.2012.011. View